- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Higher HDL cholesterol levels may increase fracture risk in elderly: JAMA
Australia: A cohort study of 16 262 community-dwelling healthy participants aged 70 years and older revealed that higher HDL-C (high-density lipoprotein cholesterol) might be linked with increased fracture risk. According to the study published in JAMA Cardiology, the association was independent of common risk factors for fractures.
The study is a post hoc analysis of data from the ASPREE (Aspirin in Reducing Events in the Elderly) clinical trial and the ASPREE-Fracture substudy.
Preclinical studies have revealed that HDL-C reduces BMD (bone mineral density) by reducing the number and function of osteoblast. Increased HDL-C levels have been associated with osteoporosis. However, there needs to be more clarity on the clinical significance of these findings. To clarify the same, Sultana Monira Hussain from Monash University in Melbourne, Australia, and colleagues aimed to determine whether higher HDL-C levels predict increased fracture risk in healthy older adults.
ASPREE was a randomized, double-blind, placebo-controlled primary prevention trial of aspirin. The trial recruited participants between 2010 and 2014, comprising community-based older adults (2411 US participants ≥65 years, 16 703 Australians aged ≥70 years) without evident dementia, cardiovascular disease, life-limiting chronic illness, and physical disability. The ASPREE-Fracture substudy collected data on fractures reported post-randomization from Australian participants.
The fractures were confirmed by medical imaging and included both minimal trauma and traumatic fractures. An expert review panel adjudicated fractures.
The study revealed the following findings:
- Of the 16 262 participants with a plasma HDL-C measurement at baseline (8945 female participants and 7319 male), 1659 experienced at least one fracture over a median (IQR) of 4.0 years.
- In a fully adjusted model, each 1-SD increment in HDL-C level was associated with a 14% higher risk of fractures (HR, 1.14). The results remained similar when these analyses were stratified by sex.
- Sensitivity and stratified analyses demonstrated that these associations persisted when the analyses were repeated to include only (1) minimal trauma fractures, (2) participants not taking osteoporosis medications, (3) participants who were never smokers and reported that they did not drink alcohol, and (4) participants who walked outside for less than 30 minutes per day and reported no participation in moderate/vigorous physical activity and to examine only (5) statin use.
- No association was observed between non–HDL-C levels and fractures.
The researchers found that higher HDL-C at baseline was tied to increased fracture risk, independent of other risk factors.
"Given the well-known inverse associations between HDL-C and heart disease, these findings suggest inconsistencies in the HDL-C's epidemiology and suggest the provocative question of whether high HDL-C could be a useful biomarker for identifying those at fracture risk," John Wilkins and Anand Rohatgi wrote in an accompanying editorial.
Reference:
Hussain SM, Ebeling PR, Barker AL, Beilin LJ, Tonkin AM, McNeil JJ. Association of Plasma High-Density Lipoprotein Cholesterol Level With Risk of Fractures in Healthy Older Adults. JAMA Cardiol. Published online January 18, 2023. doi:10.1001/jamacardio.2022.5124
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751